for

Replimune Highlights Acral Melanoma Data for RP1 plus Nivolumab at the ESMO Congress 2025

October 19, 2025 08:00 ET  | Source: Replimune, Inc. WOBURN, Mass., Oct. 19, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc.…

2 months ago

Wialon Announces Top 10 GPS Hardware Manufacturers for 2025

DUBAI, UAE, Oct. 19, 2025 /PRNewswire/ -- Teltonika Telematics has once again been recognized as the global leader in hardware for…

2 months ago

Landis+Gyr Awarded EcoVadis Platinum Medal for the Second Consecutive Year for Outstanding Sustainability Performance

CHAM, Switzerland, Oct. 16, 2025 /PRNewswire/ -- Landis+Gyr Group AG (SIX: LAND), a global leader in energy management solutions, today announced…

2 months ago

Forum Ventures Bets Big on Category-Defining Vertical AI Solution for Healthcare Growth, Salubrum

New York City, NY, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Salubrum, a vertical artificial intelligence (AI) company, has launched a…

2 months ago

IOC statement on the rejection of visas for the Israeli delegation for the upcoming Artistic Gymnastics World Championships by the government of Indonesia

18 October 2025 - In a world shaken by conflict and division, the International Olympic Committee (IOC) stands firm in its…

2 months ago

izmo Ltd. Receives Prestigious DSIR Recognition for In-House R&D Unit

BANGALORE, India, Oct. 16, 2025 /PRNewswire/ -- izmo Ltd., has been formally recognized by the Department of Scientific and Industrial…

2 months ago

How China-Fiji fisheries cooperation reels in economic vitality for the island nation

GUANGZHOU, China, Oct. 17, 2025 /PRNewswire/ -- News report from South. In Fiji, Chinese fishing vessels are doing more than…

2 months ago

Future-Ready Together: CEAT Specialty Partners with Mahindra & Mahindra for OJA Tractor Launch in Australia

CEAT Specialty chosen as the preferred OEM tyre partner for Mahindra's future-ready OJA tractor range in Australia. Range includes tyres…

2 months ago

Roche presents new phase III pivotal data for vamikibart in uveitic macular edema (UME), a serious cause of vision loss

Vamikibart is the first non-steroid targeted therapy designed to address inflammation driving UME and may offer a potential new treatment…

2 months ago

Jade Biosciences Announces New Data Presentations for JADE101 at the American Society of Nephrology Kidney Week 2025

October 17, 2025 16:05 ET  | Source: Jade Biosciences Presentations to highlight JADE101’s preclinical safety profile and translational framework guiding…

2 months ago